Annual report 2023

High-precision delivery

medmix designs, develops, manufactures and delivers innovative high-precision devices and services for the mixing, application and injection of liquids in a wide range of viscosities for the healthcare, consumer and industrial end-markets. medmix shares are listed and traded on the SIX Swiss Exchange in Zurich (Securities No. 112.967.710/ISIN CH1129677105).  
Read more about medmix here

Letter to the shareholders 

graphic graphic

Our KEY Figures

486.6 m CHF

revenue in 2023

19.1 %

adjusted EBITDA margin

3.4 m CHF

free cash flow generated in 2023

Financial Review Section

The medmix strategy: platform for growth

graphic graphic

The medmix approach to sustainability

graphic graphic